Laboratoire de Génétique Moléculaire Humaine, Faculté de Médecine de Sfax, Avenue Majida Boulila, 3029 Sfax, Tunisia.
Comput Biol Chem. 2010 Jun;34(3):203-9. doi: 10.1016/j.compbiolchem.2010.06.005. Epub 2010 Jun 25.
The intron removal during the pre-mRNA splicing in higher eukaryotes requires the accurate identification of the two splice sites at the ends of the exons, or exon definition. However, the consensus sequences at the splice sites provide insufficient information to distinguish true splice sites from the large number of the false ones that populate the primary transcripts. Additional information is provided by cis-acting regulatory sequences that serve to enhance or repress splicing, and that may be exonic or intronic in nature: the splicing enhancers and the splicing silencers, respectively. In this study, we tested by computational and statistical approaches if the exonic splicing enhancer motif binding to the SF2/ASF SR protein is conserved among several groups of human genes. The results showed that the SF2/ASF ESE consensus was conserved between genes within the same chromosome, within different chromosomes and between different levels of muscular cells differentiation. However, this motif displays subtle variations within the consensus sequence between genes expressed in different tissues. These results can emphasize the presence of different translational isoforms of the SFRS1 gene encoding for the SF2/ASF, or different post-translational protein maturations in different tissues. This tissular discrepancy can also account for the alternative splicing of several genes between tissues.
在高等真核生物的前体 mRNA 剪接过程中,内含子的去除需要准确识别exon 末端的两个剪接位点,即exon 定义。然而,剪接位点的保守序列提供的信息不足以将真正的剪接位点与大量存在于初级转录物中的假剪接位点区分开来。顺式作用调节序列提供了额外的信息,这些序列可以增强或抑制剪接,并且可以是外显子或内含子性质的:剪接增强子和剪接沉默子,分别。在这项研究中,我们通过计算和统计方法测试了 SF2/ASF SR 蛋白结合到外显子剪接增强子基序是否在几组人类基因中保守。结果表明,SF2/ASF ESE 共识在同一染色体内、不同染色体之间以及不同肌肉细胞分化水平的基因之间是保守的。然而,在不同组织中表达的基因中,该基序在保守序列内显示出细微的变化。这些结果可以强调 SFRS1 基因编码的 SF2/ASF 的不同翻译异构体的存在,或者不同组织中不同的翻译后蛋白成熟。这种组织差异也可以解释不同组织之间的几个基因的选择性剪接。